Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Vivaldi gets influenza vaccine assets from Baxter Healthcare SA

Executive Summary

Baxter International Inc.’s Switzerland-based division Baxter Healthcare SA sold vaccines developer Vivaldi Biosciences Inc. (uses reverse genetics and plasmid rescue technologies) its R&D assets and intellectual property (including clinical data, know-how, and materials) relating to live attenuated influenza vaccines with fully deleted nonstructural protein 1, also known as delta-NS1 LAIVs.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies